ClinConnect ClinConnect Logo
Search / Trial NCT05619354

Validity and Reliability of the Dutch HDI

Launched by UNIVERSITY GHENT · Nov 15, 2022

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a questionnaire called the Dutch Henry Ford Hospital Headache Disability Questionnaire (HDI) to see how well it works for patients with headaches and neck pain. The goal is to determine if this questionnaire accurately measures how headaches affect people’s daily lives. The researchers are currently looking for participants to join the study.

To be eligible, you need to be between the ages of 65 and 74 and must have been diagnosed with a type of headache by a neurologist. This includes both primary headaches (like migraines) and secondary headaches (which can be caused by other conditions). Participants should have had at least one day of headache in the last month and must speak Dutch. However, individuals with certain serious medical issues or specific types of headaches not recognized by neurology guidelines cannot participate. If you join, you’ll help improve understanding and treatment options for headache disorders.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with primary or secondary headache, diagnosed by a neurologist according to the ICHD-3 classification.
  • At least 1 day of headache in the previous month.
  • Native Dutch speaking participants
  • Exclusion Criteria:
  • All other headache types not classified by the ICHD-3 as primary or secondary headache.
  • Secondary headache in combination with underlying pathological situations (infection, trauma, tumors, brain haemorrhages) or severe psychotic or mental dysfunctions or substance use/withdrawal symptoms.

About University Ghent

University Ghent is a prestigious Belgian research institution renowned for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a multidisciplinary approach, the university fosters collaboration among leading experts in various fields, ensuring rigorous study design and ethical standards. University Ghent is dedicated to exploring new therapeutic modalities and enhancing healthcare outcomes, making significant contributions to both local and global health landscapes. Its state-of-the-art facilities and emphasis on research excellence position it as a pivotal sponsor in the realm of clinical research.

Locations

Ghent, Oost Vlaanderen, Belgium

Ghent, , Belgium

Patients applied

0 patients applied

Trial Officials

Barbara Cagnie, Prof. Dr.

Principal Investigator

University Ghent

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials